Antonio Granato1, Laura D'Acunto2, Miloš Ajčević1,3, Giovanni Furlanis1, Maja Ukmar4, Roberta Antea Pozzi Mucelli4, Paolo Manganotti1. 1. Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste - ASUGI, University of Trieste, Strada di fiume, 447 -, 34149, Trieste, Italy. 2. Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste - ASUGI, University of Trieste, Strada di fiume, 447 -, 34149, Trieste, Italy. laura.d.acun@gmail.com. 3. Department of Engineering and Architecture, University of Trieste, Trieste, Italy. 4. Radiology Unit, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste- ASUGI, University of Trieste, Trieste, Italy.
Abstract
BACKGROUND: Migrainous aura (MA) represents the third most common stroke mimic (SM). Advanced neuroimaging is pivotal in the assessment of patients with focal neurological acute symptoms. We investigated brain perfusion alterations in MA-SM patients using a novel CT perfusion (CTP)-based quantitative approach in order to improve differential diagnosis between MA and acute stroke. METHODS: We processed and analysed the clinical and neuroimaging CTP data, acquired within 4.5 h from symptom onset, of patients with acute focal neurological symptoms receiving a final diagnosis of MA. The differences between ROI, compatible with MA symptoms, and contralateral side were automatically estimated in terms of asymmetry index (AI%) by the newly developed tool for mean transit time (MTT), CBF, and cerebral blood volume (CBV) CTP parameters. The AI% ≥ 10% was considered significant. RESULTS: Out of 923 admitted patients, 14 patients with MA were included. In 13 out of 14 cases, a significant pattern of hypoperfusion was observed by quantitative analysis in at least one of the CTP maps. In 7 patients, all three CTP maps were significantly altered. In particular, MTT-AI% increased in 11 (79%) cases, while CBF-AI% and CBV-AI% decreased in 12 (86%) and in 9 (64%) patients, respectively. All CBV values were above ischemic stroke core threshold and all MTT-AI were below ischemic penumbra threshold. CONCLUSIONS: Our data suggest that a novel CTP-quantitative approach may detect during MA a moderate hypoperfusion pattern in the cerebral regions compatible with aura symptoms. The use of this novel tool could support differential diagnosis between MA and acute stroke.
BACKGROUND:Migrainous aura (MA) represents the third most common stroke mimic (SM). Advanced neuroimaging is pivotal in the assessment of patients with focal neurological acute symptoms. We investigated brain perfusion alterations in MA-SM patients using a novel CT perfusion (CTP)-based quantitative approach in order to improve differential diagnosis between MA and acute stroke. METHODS: We processed and analysed the clinical and neuroimaging CTP data, acquired within 4.5 h from symptom onset, of patients with acute focal neurological symptoms receiving a final diagnosis of MA. The differences between ROI, compatible with MA symptoms, and contralateral side were automatically estimated in terms of asymmetry index (AI%) by the newly developed tool for mean transit time (MTT), CBF, and cerebral blood volume (CBV) CTP parameters. The AI% ≥ 10% was considered significant. RESULTS: Out of 923 admitted patients, 14 patients with MA were included. In 13 out of 14 cases, a significant pattern of hypoperfusion was observed by quantitative analysis in at least one of the CTP maps. In 7 patients, all three CTP maps were significantly altered. In particular, MTT-AI% increased in 11 (79%) cases, while CBF-AI% and CBV-AI% decreased in 12 (86%) and in 9 (64%) patients, respectively. All CBV values were above ischemic stroke core threshold and all MTT-AI were below ischemic penumbra threshold. CONCLUSIONS: Our data suggest that a novel CTP-quantitative approach may detect during MA a moderate hypoperfusion pattern in the cerebral regions compatible with aura symptoms. The use of this novel tool could support differential diagnosis between MA and acute stroke.
Authors: Max Wintermark; Marie Luby; Natan M Bornstein; Andrew Demchuk; Jens Fiehler; Kohsuke Kudo; Kennedy R Lees; David S Liebeskind; Patrik Michel; Raul G Nogueira; Mark W Parsons; Makoto Sasaki; Joanna M Wardlaw; Ona Wu; Weiwei Zhang; Guangming Zhu; Steven J Warach Journal: Int J Stroke Date: 2015-04-02 Impact factor: 5.266
Authors: Laura Strada; Jonathan Y Streifler; Bruno Del Sette; Matteo Puntoni; Antonio Castaldi; Daria Bianchini; Massimo Del Sette Journal: Neurol Sci Date: 2017-07-19 Impact factor: 3.307
Authors: José G Merino; Marie Luby; Richard T Benson; Lisa A Davis; Amie W Hsia; Lawrence L Latour; John K Lynch; Steven Warach Journal: J Stroke Cerebrovasc Dis Date: 2013-05-13 Impact factor: 2.136